Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom H M Ottenhoff

Showing results (1-10 of 361) with videos related to

Pageof 37
Sort By:
Microbes and Infection|March 7, 2006
Introduction: new susceptibility genes in mycobacterial infectious diseasesTom H M Ottenhoff
Science (New York, N.Y.)|September 5, 2002
Mycobacterium leprae and demyelinationTom H M Ottenhoff
European Journal of Immunology|August 13, 2009
Overcoming the global crisis: "yes, we can", but also for TB ... ?Tom H M Ottenhoff
Leprosy Review|March 24, 2012
New insights and tools to combat leprosy nerve damageTom H M Ottenhoff
The New England Journal of Medicine|April 16, 2020
A Trial of M72/AS01E Vaccine to Prevent TuberculosisTom H M Ottenhoff
Seminars in Immunology|October 16, 2018
Correlates of vaccine adjuvanticity, vaccine activity, protective immunity and disease in human infectious disease and cancerTom H M Ottenhoff
Trends in Microbiology|July 13, 2012
New pathways of protective and pathological host defense to mycobacteriaTom H M Ottenhoff
Frontiers in Immunology|November 8, 2014
Significance of antigen and epitope specificity in tuberculosisJuraj Ivanyi, Tom H M Ottenhoff
Human Immunology|May 27, 2006
HLA and leprosy in the pre and postgenomic erasAnnemieke Geluk, Tom H M Ottenhoff
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2010
Comment on "CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infections"Simone A Joosten, Tom H M Ottenhoff
Pageof 37

Showing results (1-10 of 361) with videos related to

Sort By:
Pageof 37
Microbes and Infection|March 7, 2006
Introduction: new susceptibility genes in mycobacterial infectious diseasesTom H M Ottenhoff
Science (New York, N.Y.)|September 5, 2002
Mycobacterium leprae and demyelinationTom H M Ottenhoff
European Journal of Immunology|August 13, 2009
Overcoming the global crisis: "yes, we can", but also for TB ... ?Tom H M Ottenhoff
Leprosy Review|March 24, 2012
New insights and tools to combat leprosy nerve damageTom H M Ottenhoff
The New England Journal of Medicine|April 16, 2020
A Trial of M72/AS01E Vaccine to Prevent TuberculosisTom H M Ottenhoff
Seminars in Immunology|October 16, 2018
Correlates of vaccine adjuvanticity, vaccine activity, protective immunity and disease in human infectious disease and cancerTom H M Ottenhoff
Trends in Microbiology|July 13, 2012
New pathways of protective and pathological host defense to mycobacteriaTom H M Ottenhoff
Frontiers in Immunology|November 8, 2014
Significance of antigen and epitope specificity in tuberculosisJuraj Ivanyi, Tom H M Ottenhoff
Human Immunology|May 27, 2006
HLA and leprosy in the pre and postgenomic erasAnnemieke Geluk, Tom H M Ottenhoff
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2010
Comment on "CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infections"Simone A Joosten, Tom H M Ottenhoff
Pageof 37